259 related articles for article (PubMed ID: 12235071)
1. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.
Wong WM; Wong BC; Hung WK; Yee YK; Yip AW; Szeto ML; Fung FM; Tong TS; Lai KC; Hu WH; Yuen MF; Lam SK
Gut; 2002 Oct; 51(4):502-6. PubMed ID: 12235071
[TBL] [Abstract][Full Text] [Related]
2. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia.
Hsu PI; Lai KH; Tseng HH; Lo GH; Lo CC; Lin CK; Cheng JS; Chan HH; Ku MK; Peng NJ; Chien EJ; Chen W; Hsu PN
Aliment Pharmacol Ther; 2001 Feb; 15(2):195-201. PubMed ID: 11148437
[TBL] [Abstract][Full Text] [Related]
3. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Suzuki H; Masaoka T; Sakai G; Ishii H; Hibi T
J Gastroenterol Hepatol; 2005 Nov; 20(11):1652-60. PubMed ID: 16246181
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
[TBL] [Abstract][Full Text] [Related]
5. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
Jones R; Crouch SL
Aliment Pharmacol Ther; 1999 Mar; 13(3):413-9. PubMed ID: 10102976
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
Lindsetmo RO; Johnsen R; Revhaug A
Scand J Gastroenterol; 1998 Mar; 33(3):231-5. PubMed ID: 9548613
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).
Talley NJ; Meineche-Schmidt V; Paré P; Duckworth M; Räisänen P; Pap A; Kordecki H; Schmid V
Aliment Pharmacol Ther; 1998 Nov; 12(11):1055-65. PubMed ID: 9845395
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia.
Malfertheiner P; MOssner J; Fischbach W; Layer P; Leodolter A; Stolte M; Demleitner K; Fuchs W
Aliment Pharmacol Ther; 2003 Sep; 18(6):615-25. PubMed ID: 12969088
[TBL] [Abstract][Full Text] [Related]
10. CagA status and Helicobacter pylori eradication among dyspeptic patients.
Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
Miwa H; Nagahara A; Sato K; Ohkura R; Murai T; Shimizu H; Watanabe S; Sato N
J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
[TBL] [Abstract][Full Text] [Related]
12. Functional dyspepsia: bye-bye to PPIs.
Nyrén O
Gut; 2002 Oct; 51(4):464-5. PubMed ID: 12235062
[No Abstract] [Full Text] [Related]
13. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
[TBL] [Abstract][Full Text] [Related]
14. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
[TBL] [Abstract][Full Text] [Related]
15. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
17. Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection.
de Boer SY; Siem TH
Aliment Pharmacol Ther; 1997 Dec; 11(6):1119-21. PubMed ID: 9663839
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Hong EJ; Park DI; Oh SJ; Song MJ; Choi WH; Hong CH; Park JH; Kim HJ; Cho YK; Shon CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2008 Aug; 52(2):80-5. PubMed ID: 19077498
[TBL] [Abstract][Full Text] [Related]
19. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.
Navarro-Rodriguez T; Silva FM; Barbuti RC; Mattar R; Moraes-Filho JP; de Oliveira MN; Bogsan CS; Chinzon D; Eisig JN
BMC Gastroenterol; 2013 Mar; 13():56. PubMed ID: 23530767
[TBL] [Abstract][Full Text] [Related]
20. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]